← All diseases
Cancer
Acute myeloid leukemia
Would you like to receive a message when there is new research on Acute myeloid leukemia? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you will be notified as soon as new research on Acute myeloid leukemia is available. View what Premium costs.
Publications and studies (2129)
- Individualized physical activity program for older adults undergoing chemotherapy for hematologic malignancies. (2026/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Function and regulatory mechanism of RNA-binding protein IGF2BP2 in obesity and cancers. (2026/03/31) ♡
- Targeting systemic and tumor metabolic balances with ketogenic diets enhance efficacy of therapy in FLT3-ITD acute myeloid leukemia. (2026/03/28) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Cell line-specific antileukemic effects of imipramine: apoptosis, reactive oxygen species modulation and cytokine responses in human acute promyelocytic leukemia and chronic myelogenous leukemia cells. (2026/03/18) ♡
- Preliminary Effects of Benralizumab in an AML Cell Model with Promyelocytic Features Expressing IL-5R: An Exploratory Proof-of-Concept Study. (2026/03/13) ♡
- Long-term health-related quality of life and lifestyle behavior of patients with acute myeloid leukemia. (2026/03/09) ♡
- Pharmacological inhibition of miR-126 enhances venetoclax activity in acute myeloid leukemia. (2026/03/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Blastic Plasmacytoid Dendritic Cell Neoplasm: Updates in Diagnostic and Molecular Pathology. (2026/03/01) ♡
- SAR317461 Inhibit JAK2/STAT3 Phosphorylation for Enhanced Anti-leukemia Activity. (2026/03/01) ♡
- Nutritional and Behavioral Intervention for Long-Term Childhood Acute Leukemia Survivors With Metabolic Syndrome. (2026/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Infectious events in fit patients with relapsed or refractory acute myeloid leukemia treated with azacitidine-venetoclax or intensive chemotherapy. (2026/03/01) ♡
- Yuxingcao formula suppresses acute erythroleukemia through inhibition of AKT1 and FLI1. (2026/03/01) ♡
- Erratum: A retrospective study on effectiveness of combined recombinant human interferon-α-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease states. (2026/02/28) ♡
- Cook-Grow!: Insights from a Pilot Study on a Virtual Cooking, Gardening, and Nutrition Education Program for Childhood Cancer Survivors and their Families. (2026/02/28) ♡
- Effect of pretransplant spleen volume on the prognosis of acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation. (2026/02/17) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Venetoclax-based low-intensity therapy in pediatric AML: A viable option for chemotherapy-intolerant patients. (2026/02/15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy - a multicenter study from Polish Adult Leukemia Group. (2026/02/14) ♡
- A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinical AML models with chromosome 7 deletion. (2026/02/10) ♡
- Association between the prognostic nutritional index and early mortality of AML patients after allogeneic HSCT: a retrospective cohort analysis. (2026/02/04) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Clinical utility of interim bone marrow biopsies in FLT3 mutant acute myeloid leukemia. (2026/02/01) ♡
- Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating Agents. (2026/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Real-World Evaluation of Oral Decitabine/Cedazuridine in Elderly Patients With Acute Myeloid Leukemia. (2026/02/01) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute Leukemia. (2026/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [NK Cell Immunotherapy for Acute Myeloid Leukemia: Recent Advances and the Immunomodulatory Role of Traditional Chinese Medicine--Review]. (2026/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Indolent Acute Promyelocytic Leukemia. (2026/01/27) ♡
- Bioelectrical Impedance and GLIM Criteria Identify Early Nutritional Deterioration and Mortality in Acute Leukemia Patients Undergoing Chemotherapy. (2026/01/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Novel therapeutic strategies targeting resistance mechanisms in hematologic malignancies: from BCL2 inhibition to immunomodulatory approaches. (2026/01/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. NCOA4 and ferritinophagy in hematological malignancies: a double-edged regulator of iron metabolism and cell fate. (2026/01/20) ♡
- A study of clinical profile and outcomes of paediatric patients with acute myeloid leukaemia. (2026/01/20) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. CD79B in myelodysplastic syndromes and acute myeloid leukemia: an integrative computational and in vitro study. (2026/01/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: FIA plus venetoclax in a patient on hemodialysis. (2026/01/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fanconi Anemia. (2026/01/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Pediatric AML with TBC1D15::RAB21 fusion and FLT3-ITD/NPM1 co-mutation: diagnostic pitfalls in morphologic mimicry of acute promyelocytic leukemia. (2026/01/13) ♡
- Identification and validation of HOXB3 hypomethylation as a novel prognostically epigenetic biomarker in acute myeloid leukemia. (2026/01/12) ♡
- Modified EASIX score on day 7 predicts survival and non-relapse mortality in pediatric acute leukemia undergoing haploidentical stem cell transplantation. (2026/01/12) ♡
- Donor lymphocyte infusion combined with azacitidine after allogeneic HSCT in pediatric AML: a single-center retrospective analysis. (2026/01/08) ♡
- Venetoclax concentration affects the incidence of haematological adverse events in patients with acute myeloid leukaemia. (2026/01/07) ♡
- Prediction of prognosis and immunotherapy response of tryptophan metabolism genes in acute myeloid leukemia. (2026/01/07) ♡
- Toward the future management of patients with CML and Ph + ALL: real-world safety insights from dasatinib pharmacovigilance. (2026/01/06) ♡
- scVAR: integrating genomics and transcriptomics from single-cell RNA-seq -insights from leukemia case studies. (2026/01/05) ♡
- Dominant TET2 mutations predict adverse prognosis in cytogenetically normal acute myeloid leukemia patients. (2026/01/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Myeloid sarcoma masquerading as central nervous system diffuse large b-cell lymphoma: a case report and literature review. (2026/01/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hotspot gene mutations and treatment response in myelodysplastic syndromes (MDS): predictive biomarkers and targeted strategies. (2026/01/05) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Identification of TP53 (C135fs*35) and NF1 Mutations with Biallelic Alterations in Acute Myeloid Leukemia with Complex Karyotype: Expanding the Mutational Spectrum of Hematologic Malignancies. (2026/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Myeloid Sarcoma as Presenting Feature of Late Isolated Central Nervous System Relapse Post-Bone Marrow Transplant. (2026/01/01) ♡
- Clinicopathologic Spectrum of Dermatological Diseases in Patients with Acute Myeloid Leukemia (AML): A Retrospective Study in AML Patients with Cutaneous Manifestations. (2026/01/01) ♡
- Cup-Like Blasts in B-Lymphoblastic Leukemia with KMT2A Rearrangement: A Rare Morphological Presentation. (2026/01/01) ♡
- CRISPR-Cas9 knockout screens to identify drug resistance genes in acute myeloid leukemia. (2026/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Synergistic protective effects of melatonin and ascorbic acid against benzene-induced genotoxicity, oxidative stress, and activin A/follistatin dysregulation in a rat model of pre-leukemia. (2026/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Long-term remission with venetoclax plus azacitidine in acute myeloid leukemia with negative conversion of FLT3 companion diagnostic testing at relapse]. (2026/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.